Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease of serum angiotensin converting enzyme activity after discontinuation of captopril treatment.

T Forslund, I Tikkanen, F Fyhrquist

    Acta Pharmacologica Et Toxicologica
    |July 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A sham-controlled randomised pilot trial on baroreflex activation therapy in patients with resistant hypertension: What will the future hold?

    Blood pressure·2024
    Same author

    Heterogeneity after harmonisation: A retrospective cohort study of bleeding and stroke risk after the introduction of direct oral anticoagulants in four Western European countries.

    Pharmacoepidemiology and drug safety·2023
    Same author

    Lowering Albuminuria-Does It Lower the Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.

    Journal of the American Society of Nephrology : JASN·2023
    Same author

    Reducing Microalbuminuria-Does It Lower Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.

    Journal of the American Society of Nephrology : JASN·2023
    Same author

    Trends in psychiatric diagnoses, medications and psychological therapies in a large Swedish region: a population-based study.

    BMC psychiatry·2020
    Same author

    Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes.

    Diabetes, obesity & metabolism·2015

    Captopril treatment reversibly increases rat serum angiotensin-converting enzyme (ACE) biosynthesis. Serum ACE activity returns to baseline levels within 12 days of drug withdrawal, indicating a reversible effect.

    Area of Science:

    • Pharmacology
    • Biochemistry
    • Physiology

    Background:

    • Angiotensin-converting enzyme (ACE) plays a crucial role in the renin-angiotensin system.
    • ACE inhibitors, like captopril, are widely used to treat hypertension and heart failure.
    • Understanding the reversibility of ACE modulation is important for clinical practice.

    Purpose of the Study:

    • To investigate the reversibility of captopril-induced changes in serum and lung ACE activity and concentration in rats.
    • To determine the half-life of serum ACE activity after captopril discontinuation.

    Main Methods:

    • Wistar rats were treated with captopril (30 mg/kg/day) for six weeks.
    • Serum ACE activity was measured at baseline and at 3, 6, and 12 days post-treatment.
    • Lung ACE concentration in plasma membranes and homogenates was assessed 12 days after captopril withdrawal.

    Related Experiment Videos

    Main Results:

    • Serum ACE activity increased approximately three-fold during captopril treatment.
    • The estimated half-life of serum ACE activity after captopril withdrawal was 72 hours.
    • No significant differences in lung ACE concentration were observed between treated and control rats 12 days after discontinuation.

    Conclusions:

    • Captopril-induced ACE biosynthesis in rats is reversible upon drug withdrawal.
    • Serum ACE activity normalizes within approximately 12 days after cessation of captopril treatment.
    • Lung ACE concentration remains unaffected long-term after captopril discontinuation.